Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities.
暂无分享,去创建一个
W E Reddick | J W Langston | R G Steen | J S Taylor | J O Glass | W. Reddick | J. Glass | J. Langston | R. Steen | J. S. Taylor | E. Pivnick | June S. Taylor | E K Pivnick | V R Brewer | R Mages | V. Brewer | R. Mages | J. Langston | Roy Mages
[1] J. Friedman,et al. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. , 1997, American journal of medical genetics.
[2] S. Huson,et al. Von Recklinghausen neurofibromatosis: a clinical and population study in south-east Wales , 1988 .
[3] K. North,et al. Specific learning disability in children with neurofibromatosis type 1 , 1994, Neurology.
[4] K. Yamashita,et al. Development and aging of brain midline structures: assessment with MR imaging. , 1989, Radiology.
[5] E. Reiman,et al. Positron Emission Tomography in Children With Neurofibromatosis-1 , 1997, Journal of child neurology.
[6] K. Krishnan,et al. MRI morphometric analysis and neuropsychological function in patients with neurofibromatosis. , 1996, Neuroreport.
[7] R. Ferner,et al. Intellectual impairment in neurofibromatosis 1 , 1996, Journal of the Neurological Sciences.
[8] A. Zvulunov,et al. Neurofibromatosis Type 1 in Childhood: Evaluation of Clinical and Epidemiologic Features as Predictive Factors for Severity , 1998, Clinical pediatrics.
[9] R. Mulhern,et al. Subtle brain abnormalities in children with sickle cell disease: Relationship to blood hematocrit , 1999, Annals of neurology.
[10] D. Gutmann,et al. Recent insights into neurofibromatosis type 1: clear genetic progress. , 1998, Archives of neurology.
[11] J. Dambrosia,et al. Neurofibromatosis type 1 (Recklinghausen's disease). Neurologic and cognitive assessment with sibling controls. , 1989, American journal of diseases of children.
[12] P. O'Connell,et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations , 1990, Cell.
[13] D. Wechsler. Wechsler Intelligence Scale for Children , 2020, Definitions.
[14] W. Reddick,et al. A hybrid neural network analysis of subtle brain volume differences in children surviving brain tumors. , 1998, Magnetic resonance imaging.
[15] W. Reddick,et al. Statistical error mapping for reliable quantitative T1 imaging , 1996, Journal of magnetic resonance imaging : JMRI.
[16] D. Gutmann,et al. Developmental regulation of a neuron‐specific neurofibromatosis 1 isoform , 1999, Annals of neurology.
[17] A. Barkovich,et al. Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1. , 1996, AJNR. American journal of neuroradiology.
[18] G. Scotti,et al. Spontaneous involution of optic pathway lesions in neurofibromatosis type 1: serial contrast MR evaluation. , 1995, AJNR. American journal of neuroradiology.
[19] W. Kaufmann,et al. Thalamic involvement in neurofibromatosis type 1: Evaluation with proton magnetic resonance spectroscopic imaging , 2000, Annals of neurology.
[20] R. Steen,et al. Age‐related changes in proton T1 values of normal human brain , 1995, Journal of magnetic resonance imaging : JMRI.
[21] S. Ozonoff,et al. Cognitive impairment in neurofibromatosis type 1. , 1999, American journal of medical genetics.
[22] D. Norman,et al. Neurofibromatosis types 1 and 2: cranial MR findings. , 1989, Radiology.
[23] Linda J. Schuerholz,et al. Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1. , 1996, American journal of medical genetics.
[24] B. Moore,et al. Brain volume in children with neurofibromatosis type 1 , 2000, Neurology.
[25] J. I. P. James,et al. Recognizable Patterns of Human Malformation. Genetic, Embryologic and Clinical Aspects , 1971 .
[26] Edwin N. Cook,et al. Automated segmentation and classification of multispectral magnetic resonance images of brain using artificial neural networks , 1997, IEEE Transactions on Medical Imaging.
[27] Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. , 1988, Archives of neurology.
[28] B. Cohen. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis, 2nd Ed. , 1992 .
[29] R. Bryan,et al. Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities. , 1994, AJNR. American journal of neuroradiology.
[30] A. Barkovich,et al. Evolution of white matter lesions in neurofibromatosis type 1: MR findings. , 1992, AJR. American journal of roentgenology.
[31] W. Reddick,et al. Quantitative MRI of the brain in children with sickle cell disease reveals abnormalities unseen by conventional MRI , 1998, Journal of magnetic resonance imaging : JMRI.
[32] W E Reddick,et al. Hybrid artificial neural network segmentation of precise and accurate inversion recovery (PAIR) images from normal human brain. , 2000, Magnetic resonance imaging.
[33] F. Collins,et al. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients , 1992, Nature.
[34] G. Ramsby,et al. Magnetic resonance imaging lesion analysis in neurofibromatosis type 1. , 1998, Archives of neurology.
[35] W E Reddick,et al. Age-related changes in the pediatric brain: quantitative MR evidence of maturational changes during adolescence. , 1997, AJNR. American journal of neuroradiology.
[36] D. Gutmann,et al. Increased expression of the neurofibromatosis 1 (NF1) gene product, neurofibromin, in astrocytes in response to cerebral ischemia , 1996, Journal of neuroscience research.
[37] R. Steen,et al. Precise and accurate measurement of proton T1 in human brain in vivo: Validation and preliminary clinical application , 1994, Journal of magnetic resonance imaging : JMRI.
[38] D. Grobbee,et al. Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital. , 1998, Journal of medical genetics.
[39] W. Reddick,et al. More than meets the eye: significant regional heterogeneity in human cortical T1. , 2000, Magnetic resonance imaging.
[40] W E Reddick,et al. Correction of errors caused by imperfect inversion pulses in MR imaging measurement of T1 relaxation times. , 1998, Magnetic resonance imaging.
[41] R. Hughes,et al. MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[42] D. Shucard,et al. The significance of MRI abnormalities in children with neurofibromatosis , 1989, Neurology.
[43] P. Griffiths,et al. Neurofibromatosis Bright Objects in Children With Neurofibromatosis Type 1: A Proliferative Potential? , 1999, Pediatrics.
[44] P. Rakić,et al. Development of the corpus callosum and cavum septi in man , 1968, The Journal of comparative neurology.
[45] W. Reddick,et al. Establishing norms for age-related changes in proton T1 of human brain tissue in vivo. , 1997, Magnetic resonance imaging.
[46] B. Moore,et al. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis , 1996, Neurology.
[47] K. Jones,et al. Smith's Recognizable Patterns of Human Malformation , 1996 .